Viewpoints Cover The Waterfront At FDA Nicotine Replacement Therapy Policy Hearing
Executive Summary
FDA added to the docket for its initiative evaluating nicotine replacement therapies reference materials including a meta-analysis on efficacy of NRTs in smoking cessation and a report on quitting smoking among adults in the US, 2000-2015.
You may also be interested in...
FDA's Nicotine Replacement Standards Review Could Open Door For E-Cigarettes
Latest steps by US FDA targeting tobacco-related health problems are a Nicotine Steering Committee, headed by Commissioner Gottlieb, and a public docket, including a meeting in January, for suggestions on how novel products could be evaluated as safe and effective NRTs.
Gottlieb Adds A No. 2: Sherman Is US FDA Principal Deputy Commissioner
Rachel Sherman takes over a position that has not been filled permanently since Josh Sharfstein left in 2011.
Federal court lifts import ban on e-cigarettes
The U.S. District Court for the District of Columbia grants electronic cigarette distributors a preliminary injunction that allows them to be classified as tobacco products. The decision overturns FDA's interpretation that the products were unapproved drug devices and agrees with arguments made by law firm Latham & Watkins on behalf of Sottera, a distributor of e-cigarette brand Njoy, according to a Jan. 14 release. FDA in July warned consumers about the e-cigarettes and stopped shipments from entering the U.S. because tested lots contained toxic materials (1"The Tan Sheet" July 27, 2009)